CAMPTON Diagnostics

Taking POC diagnostics to the next level in lab testing! At CAMPTON Diagnostics we believe that faster and more accessible diagnostics will improve patient outcomes leading to a longer and healthier life. With the new CAMPTON we introduc a true point-of-care platform enabling while-you-wait results for enhanced disease treatment and management. CAMPTON Diagnostics GmbH was spun off from the Fraunhofer Institute for Silicon Technology (ISIT) in Itzehoe in 2016. The company develops and markets complete measuring systems for point-of-care diagnostics, i.e. for on-site examinations of patients. CAMPTON Diagnostics combines biotechnological and engineering know-how under one roof. The “Biochip Reader” device developed by CAMPTON uses silicon-based biochips from Fraunhofer ISIT. The ISIT produces these in the institute’s own clean room. The system, which is based on “electrical biochip technology”, can be used to obtain reliable information on the indication of infections, cancer or other diseases from a few microlitres of whole blood within a few minutes. The tests are particularly fast, highly sensitive and enable the simultaneous measurement of several parameters in one sample. Disposable cartridges with an integrated biochip are used for the measurements. The biochip functions like a conventional ELISA test, but is electrically readable and therefore extremely miniaturizable. The “Biochip Reader” performs the measurement fully automatically. After a few minutes, the analysis result is shown on the display as a real value.